Anthera Pharmaceuticals (NASDAQ: ANTH) is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases. Its lead product blisibimod is a selective peptibody against the B-cell activating factor (BAFF), a component of the TNF pathway.

anthera.com